Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Wan Hui Shuang He Pharmaceutical is a specialized pharmaceutical manufacturer based in Beijing and a core subsidiary of China Resources Double-Crane Pharmaceutical. The company focuses on the production of chemical drugs, particularly in the fields of cardiovascular disease, diabetes, and pediatrics. It is well-known for its expertise in sustained-release technology and has successfully passed consistency evaluations for several key generic products. Wan Hui Shuang He operates modern production lines that meet high-quality GMP standards, ensuring a steady supply of essential medicines to the Chinese market. As part of the larger China Resources Group, it leverages extensive distribution networks and R&D resources to maintain its competitive position in the generic drug industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Wan Hui Shuang He Pharmaceutical.